CYTK FY 2009 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena

CYTKCytokinetics, Incorporated

$7B

FY 2009 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$82M+556.5% YoY

Gross Profit

$82M100.0% margin

Operating Income

$26M32.0% margin

Net Income

$25M30.1% margin

EPS (Diluted)

$2.52

Cash Flow

Operating Cash Flow

$8M

Free Cash Flow

$8M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$123M

Total Liabilities

$21M

Stockholders' Equity

$101M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$82M	$12M	+556.5%
Gross Profit	$82M	$12M	+556.5%
Operating Income	$26M	-$59M	+144.2%
Net Income	$25M	-$56M	+143.5%